HomeCompareNDBKF vs PFE

NDBKF vs PFE: Dividend Comparison 2026

NDBKF yields 6.63% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NDBKF wins by $32205.10M in total portfolio value
10 years
NDBKF
NDBKF
● Live price
6.63%
Share price
$17.15
Annual div
$1.14
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32205.15M
Annual income
$31,298,814,566.54
Full NDBKF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — NDBKF vs PFE

📍 NDBKF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNDBKFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NDBKF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NDBKF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NDBKF
Annual income on $10K today (after 15% tax)
$563.89/yr
After 10yr DRIP, annual income (after tax)
$26,603,992,381.56/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, NDBKF beats the other by $26,603,970,061.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NDBKF + PFE for your $10,000?

NDBKF: 50%PFE: 50%
100% PFE50/50100% NDBKF
Portfolio after 10yr
$16102.60M
Annual income
$15,649,420,412.63/yr
Blended yield
97.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

NDBKF
No analyst data
Altman Z
0.3
Piotroski
7/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NDBKF buys
0
PFE buys
0
No recent congressional trades found for NDBKF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNDBKFPFE
Forward yield6.63%6.13%
Annual dividend / share$1.14$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$32205.15M$49.6K
Annual income after 10y$31,298,814,566.54$26,258.71
Total dividends collected$32142.70M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NDBKF vs PFE ($10,000, DRIP)

YearNDBKF PortfolioNDBKF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$12,027$1,326.81$9,153$693.39+$2.9KNDBKF
2$15,851$2,982.67$8,593$849.25+$7.3KNDBKF
3$24,309$7,347.98$8,336$1,066.78+$16.0KNDBKF
4$47,073$21,062.67$8,437$1,384.80+$38.6KNDBKF
5$126,606$76,237.35$9,013$1,875.40+$117.6KNDBKF
6$518,728$383,259.79$10,306$2,680.72+$508.4KNDBKF
7$3,490,158$2,935,119.61$12,820$4,101.38+$3.48MNDBKF
8$40,647,319$36,912,849.14$17,673$6,826.70+$40.63MNDBKF
9$847,038,263$803,545,631.88$27,543$12,591.86+$847.01MNDBKF
10$32,205,145,508$31,298,814,566.54$49,560$26,258.71+$32205.10MNDBKF

NDBKF vs PFE: Complete Analysis 2026

NDBKFStock

Nedbank Group Limited, together with its subsidiaries, provides various wholesale and retail banking services in South Africa and internationally. It offers personal banking solutions, including savings deposits and investment accounts; home and personal loans, student loans, vehicle finance products, private wealth finance solutions, overdrafts, short term loans, and credit cards; and investment plans and services, financial, and estate planning services, and wills and trust services, as well as professional banking, wealth management, non-resident and embassy banking, insurance, stock broking, and foreign exchange services. The company also provides business banking services, such as business accounts; call, fixed, and flexi deposits; loans and structured solutions; property, asset, and vehicle finance products; value added services; card and cash solutions; treasury solutions; cash management, electronic banking, and merchant payment and support services; life, asset, income and credit protection, funeral, business cover, liability cover, revenue cover, and owners' insurance products; asset management services; and commodities, equities, fixed income, and structured credit products. In addition, the company offers corporate banking services comprising aircraft, asset based, carbon, export credit, global commodity, infrastructure, energy, telecoms, leveraged, mining, oil and gas, private equity, and public sector finance; payments and receipts, documentary credits and collections, guarantees, and trade finance; structured solutions; corporate lending and advances; custodial services; corporate finance and debt advisory services; beta solutions; and corporate and institutional investments. Further, it provides transactional banking services. The company was formerly known as Nedcor Limited and changed its name to Nedbank Group Limited in 2005. Nedbank Group Limited was founded in 1831 and is headquartered in Sandton, South Africa.

Full NDBKF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this NDBKF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NDBKF vs SCHDNDBKF vs JEPINDBKF vs ONDBKF vs KONDBKF vs MAINNDBKF vs JNJNDBKF vs MRKNDBKF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.